Bayer, J&J win reversal of $28 million verdict in Xarelto lawsuit

(Reuters) - A Pennsylvania state court judge on Tuesday overturned a $27.8 million jury award to an Indiana couple who accused Bayer AG and Johnson & Johnson of failing to warn of internal bleeding risks of their drug Xarelto, the companies said.